^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    doxorubicin encapsulated nanocells (EGFREDVDox)

    i
    Other names: EGFREDVDox, Doxorubicin packaged EDV nanocells, Doxorubicin-loaded EDV nanocells, EGFR(V)-EDV-Dox, cerebral EDV, EGFR targeted EDV-Dox
    Associations

    News

    Trials
    Company:
    EnGeneIC
    Drug class:
    DNA topoisomerase inhibitor
    Related drugs:
    Associations

    News

    Trials
    6ms
    CerebralEDV: A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM (clinicaltrials.gov)
    P1, N=9, Completed, Engeneic Pty Limited | Unknown status --> Completed | N=20 --> 9
    Trial completion • Enrollment change
    |
    Vectibix (panitumumab) • doxorubicin hydrochloride • doxorubicin encapsulated nanocells (EGFREDVDox)